Contributions  Estimated Future Benefit Payments Savings Plan  Post Employment Benefit Plan  Termination Indemnity Plans  The following summarizes the activity for financial assets utilizing Level 3 fair value measurements:  The investment strategy emphasizes equities in order to achieve higher expected returns and lower expenses and required cash  contributions over the long-term. A target asset allocation of 70% public equity (58% U.S. and 12% international), 8% private equity  and 22% fixed income is maintained for the U.S. pension plans. Investments are well diversified within each of the three major asset  categories. Approximately 81% of the U.S. pension plans equity investments are actively managed. Venture capital and limited  partnerships are typically valued on a three month lag. BMS Company common stock represents less than 1% of the plan assets at  December 31, 2012 and 2011.  Contributions to the U.S. pension plans were $335 million in 2012, $343 million in 2011 and $341 million in 2010.  Contributions to the international pension plans were $61 million in 2012, $88 million in 2011 and $90 million in 2010. Aggregate  contributions to the U.S. and international plans are expected to be $100 million in 2013.  The principal defined contribution plan is the Bristol-Myers Squibb Savings and Investment Program. The contribution is based on  employee contributions and the level of Company match. The expense related to the plan was $190 million in 2012, $181 million in  2011 and $188 million in 2010.  Post-employment liabilities for long-term disability benefits were $90 million and $92 million at December 31, 2012 and 2011,  respectively. The expense related to these benefits was $17 million in 2012 and $18 million in both 2011 and 2010.  Statutory termination obligations are recognized on an undiscounted basis assuming employee termination at each measurement date. The liability recognized for these obligations was $29 million and $25 million at December 31, 2012 and 2011, respectively.  62 Pension  Other  Dollars in Millions Benefits Benefits 2013 $   385 $  47 2014   398  44 2015   401  42 2016   415  40 2017   422  37 Years 2018 – 2022   2,109  151 Venture Capital  and Limited  Insurance  Dollars in Millions Partnerships Contracts  Other  Total  Fair value at January 1, 2011 $  415 $  144 $   39 $  598  Purchases   53  8  5  66  Sales   (5)  (31)  (3)  (39) Settlements   (48)  -  (4)  (52) Realized (losses)/gains   56  3  59  Unrealized gains/(losses)   (63)  4  (7)  (66) Fair value at December 31, 2011   408  125  33  566  Purchases   43  5  -  48  Sales   (8)  (7)  (10)  (25) Settlements   (51)  -  (2)  (53) Realized (losses)/gains   53  (4)  49  Unrealized gains/(losses)   (64)  9  6  (49) Fair value at December 31, 2012  $  381 $  132 $   23 $  536  Bristol-Myers Squibb 